| William I Birsic, MD | |
|
44 S Washington Ave, Greensburg, PA 15601-2768 | |
| (724) 689-1335 | |
| (724) 689-1337 |
| Full Name | William I Birsic |
|---|---|
| Gender | Male |
| Speciality | General Surgery |
| Experience | 39 Years |
| Location | 44 S Washington Ave, Greensburg, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1851307854 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2086S0127X | Surgery - Trauma Surgery | MD037323E (Pennsylvania) | Secondary |
| 208600000X | Surgery | 036-099223 (Illinois) | Secondary |
| 208600000X | Surgery | MD037323E (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Excela Health Westmoreland Regional Hospital | Greensburg, PA | Hospital |
| Excela Health Latrobe Hospital | Latrobe, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Excela Health Physician Practices, Inc | 6204737117 | 438 |
News Archive
University of Louisville researchers are uncovering better ways for insurers and health care providers to comply with the US health care bill President Obama signed into law.
High-flux hemodialysis (which removes large toxins) reduces the risk of premature death in many patients with chronic kidney disease (CKD), according to a study appearing in the March 2009 issue of the Journal of the American Society Nephrology (JASN).
A scheme launched by the Department of Health in 2011 to help patients stick to their drug regimens has been so successful, that in its first five years, it will save NHS England £517.6m in the long-term, a team of health economists has found.
Angion Biomedica Corp., a biopharmaceutical company dedicated to the discovery and development of novel therapeutics that enhance quality of life, eradicate disease and save lives by modulating the body's protective, reparative and regenerative systems, announced today that its lead therapeutic BB3 was accepted into the Fast Track program of the U.S. Food and Drug Administration (FDA) and has also been designated an Orphan Drug product by FDA.
Just six months of exercise can improve memory, language, thinking and judgment problems by almost 50 per cent, says a study presented today at the Canadian Stroke Congress.
› Verified 4 days ago
| Entity Name | The Milton S Hershey Medical Center Physicians Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710951744 PECOS PAC ID: 3870405483 Enrollment ID: O20040225000741 |
News Archive
University of Louisville researchers are uncovering better ways for insurers and health care providers to comply with the US health care bill President Obama signed into law.
High-flux hemodialysis (which removes large toxins) reduces the risk of premature death in many patients with chronic kidney disease (CKD), according to a study appearing in the March 2009 issue of the Journal of the American Society Nephrology (JASN).
A scheme launched by the Department of Health in 2011 to help patients stick to their drug regimens has been so successful, that in its first five years, it will save NHS England £517.6m in the long-term, a team of health economists has found.
Angion Biomedica Corp., a biopharmaceutical company dedicated to the discovery and development of novel therapeutics that enhance quality of life, eradicate disease and save lives by modulating the body's protective, reparative and regenerative systems, announced today that its lead therapeutic BB3 was accepted into the Fast Track program of the U.S. Food and Drug Administration (FDA) and has also been designated an Orphan Drug product by FDA.
Just six months of exercise can improve memory, language, thinking and judgment problems by almost 50 per cent, says a study presented today at the Canadian Stroke Congress.
› Verified 4 days ago
| Entity Name | Excela Health Physician Practices, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1821225202 PECOS PAC ID: 6204737117 Enrollment ID: O20040322001393 |
News Archive
University of Louisville researchers are uncovering better ways for insurers and health care providers to comply with the US health care bill President Obama signed into law.
High-flux hemodialysis (which removes large toxins) reduces the risk of premature death in many patients with chronic kidney disease (CKD), according to a study appearing in the March 2009 issue of the Journal of the American Society Nephrology (JASN).
A scheme launched by the Department of Health in 2011 to help patients stick to their drug regimens has been so successful, that in its first five years, it will save NHS England £517.6m in the long-term, a team of health economists has found.
Angion Biomedica Corp., a biopharmaceutical company dedicated to the discovery and development of novel therapeutics that enhance quality of life, eradicate disease and save lives by modulating the body's protective, reparative and regenerative systems, announced today that its lead therapeutic BB3 was accepted into the Fast Track program of the U.S. Food and Drug Administration (FDA) and has also been designated an Orphan Drug product by FDA.
Just six months of exercise can improve memory, language, thinking and judgment problems by almost 50 per cent, says a study presented today at the Canadian Stroke Congress.
› Verified 4 days ago
| Entity Name | Spirit Physician Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093013328 PECOS PAC ID: 8022922202 Enrollment ID: O20040402000053 |
News Archive
University of Louisville researchers are uncovering better ways for insurers and health care providers to comply with the US health care bill President Obama signed into law.
High-flux hemodialysis (which removes large toxins) reduces the risk of premature death in many patients with chronic kidney disease (CKD), according to a study appearing in the March 2009 issue of the Journal of the American Society Nephrology (JASN).
A scheme launched by the Department of Health in 2011 to help patients stick to their drug regimens has been so successful, that in its first five years, it will save NHS England £517.6m in the long-term, a team of health economists has found.
Angion Biomedica Corp., a biopharmaceutical company dedicated to the discovery and development of novel therapeutics that enhance quality of life, eradicate disease and save lives by modulating the body's protective, reparative and regenerative systems, announced today that its lead therapeutic BB3 was accepted into the Fast Track program of the U.S. Food and Drug Administration (FDA) and has also been designated an Orphan Drug product by FDA.
Just six months of exercise can improve memory, language, thinking and judgment problems by almost 50 per cent, says a study presented today at the Canadian Stroke Congress.
› Verified 4 days ago
| Entity Name | Penn State Health Community Medical Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861988644 PECOS PAC ID: 8729351077 Enrollment ID: O20170907002279 |
News Archive
University of Louisville researchers are uncovering better ways for insurers and health care providers to comply with the US health care bill President Obama signed into law.
High-flux hemodialysis (which removes large toxins) reduces the risk of premature death in many patients with chronic kidney disease (CKD), according to a study appearing in the March 2009 issue of the Journal of the American Society Nephrology (JASN).
A scheme launched by the Department of Health in 2011 to help patients stick to their drug regimens has been so successful, that in its first five years, it will save NHS England £517.6m in the long-term, a team of health economists has found.
Angion Biomedica Corp., a biopharmaceutical company dedicated to the discovery and development of novel therapeutics that enhance quality of life, eradicate disease and save lives by modulating the body's protective, reparative and regenerative systems, announced today that its lead therapeutic BB3 was accepted into the Fast Track program of the U.S. Food and Drug Administration (FDA) and has also been designated an Orphan Drug product by FDA.
Just six months of exercise can improve memory, language, thinking and judgment problems by almost 50 per cent, says a study presented today at the Canadian Stroke Congress.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| William I Birsic, MD 44 S Washington Ave, Greensburg, PA 15601-2768 Ph: (724) 689-1335 | William I Birsic, MD 44 S Washington Ave, Greensburg, PA 15601-2768 Ph: (724) 689-1335 |
News Archive
University of Louisville researchers are uncovering better ways for insurers and health care providers to comply with the US health care bill President Obama signed into law.
High-flux hemodialysis (which removes large toxins) reduces the risk of premature death in many patients with chronic kidney disease (CKD), according to a study appearing in the March 2009 issue of the Journal of the American Society Nephrology (JASN).
A scheme launched by the Department of Health in 2011 to help patients stick to their drug regimens has been so successful, that in its first five years, it will save NHS England £517.6m in the long-term, a team of health economists has found.
Angion Biomedica Corp., a biopharmaceutical company dedicated to the discovery and development of novel therapeutics that enhance quality of life, eradicate disease and save lives by modulating the body's protective, reparative and regenerative systems, announced today that its lead therapeutic BB3 was accepted into the Fast Track program of the U.S. Food and Drug Administration (FDA) and has also been designated an Orphan Drug product by FDA.
Just six months of exercise can improve memory, language, thinking and judgment problems by almost 50 per cent, says a study presented today at the Canadian Stroke Congress.
› Verified 4 days ago
Dr. Arshad Malik Bachelani, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 44 S Washington Ave, Greensburg, PA 15601 Phone: 724-689-1335 Fax: 724-689-1337 | |
Jodi M Telli, PA-C Surgery Medicare: Accepting Medicare Assignments Practice Location: 44 S Washington Ave, Greensburg, PA 15601 Phone: 724-689-1335 Fax: 724-689-1337 | |
Mr. Francis Regis Johns Jr., M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 6154 State Route 30, Suite 100, Greensburg, PA 15601 Phone: 724-830-9305 Fax: 724-830-9356 | |
Dr. John Domit, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 532 W Pittsburgh St, Greensburg, PA 15601 Phone: 724-832-4450 Fax: 724-830-6669 | |
Sarah Dunn Treter, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 44 S Washington Ave, Greensburg, PA 15601 Phone: 724-689-1335 Fax: 724-689-1337 | |
Dr. Mark A. Zelkovic, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 530 South St, Suite 300, Greensburg, PA 15601 Phone: 724-850-3142 Fax: 724-850-3143 | |
Paul Malaspina, Surgery Medicare: Accepting Medicare Assignments Practice Location: 44 S Washington Ave, Greensburg, PA 15601 Phone: 724-689-1335 Fax: 724-689-1337 |